Interview with CEO of StemTek Therapeutics, Dr. Angel Garcia Martin

About BioNeex BioNeex is an online, peer-to-peer platform for R&D-stage licensing and collaborative partnerships in the biopharmaceutical industry. In other words, BioNeex provides a user-friendly infrastructure for preclinical and clinical stage biotech companies to display their novel compounds available for licensing and co-development partnerships on a global scale. On the other hand, the platform offers pharmaceutical companies a direct access to such innovative compounds, which will enable them to fill their R&D pipeline. About StemTek Therapeutics StemTek Therapeutics is a start-up biotechnology company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells.